HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liang Tang Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2022Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis.
6/2017A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liang Tang Research Topics

Disease

77Neoplasms (Cancer)
01/2024 - 08/2003
20Neoplasm Metastasis (Metastasis)
04/2024 - 10/2005
19Hepatocellular Carcinoma (Hepatoma)
01/2018 - 08/2003
16Myocardial Infarction
10/2023 - 01/2006
15Lung Neoplasms (Lung Cancer)
06/2022 - 12/2005
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2018 - 10/2005
13Thrombosis (Thrombus)
06/2021 - 08/2003
11Inflammation (Inflammations)
01/2023 - 10/2010
9Infections
09/2023 - 06/2005
9Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 02/2013
8COVID-19
04/2024 - 01/2020
8Breast Neoplasms (Breast Cancer)
08/2023 - 11/2012
8Hypoxia (Hypoxemia)
10/2021 - 09/2015
8Carcinogenesis
01/2020 - 12/2007
7Alzheimer Disease (Alzheimer's Disease)
01/2024 - 09/2016
7Hemorrhage
06/2023 - 05/2007
7Fibrosis (Cirrhosis)
01/2023 - 06/2004
6Atherosclerosis
10/2023 - 01/2016
6ST Elevation Myocardial Infarction
01/2022 - 09/2011
6Heart Failure
09/2021 - 06/2009
6Obesity
01/2021 - 12/2011
6Body Weight (Weight, Body)
10/2019 - 08/2004
5Myocardial Ischemia (Ischemic Heart Diseases)
10/2023 - 12/2012
5Atrial Fibrillation
03/2023 - 09/2007
5Venous Thromboembolism
01/2023 - 09/2017
5Wounds and Injuries (Trauma)
09/2022 - 09/2009
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2006
5Disease Progression
10/2020 - 07/2009
5Reperfusion Injury
10/2018 - 02/2017
4Fatigue
04/2024 - 05/2005
4Osteoporosis
12/2023 - 03/2013
4Multiple Myeloma
01/2023 - 01/2016
4Muscular Atrophy (Muscle Atrophy)
01/2023 - 07/2018
4Atrophy
05/2021 - 01/2014
4Ischemia
01/2021 - 05/2007
4Insulin Resistance
10/2019 - 10/2013
4Cholangiocarcinoma
04/2013 - 10/2005
4Adenocarcinoma of Lung
02/2013 - 05/2010
3Virus Diseases (Viral Diseases)
05/2024 - 03/2021
3Adenocarcinoma
01/2024 - 12/2007
3Hypertension (High Blood Pressure)
12/2023 - 01/2020
3Stroke (Strokes)
10/2023 - 09/2018
3Death (Near-Death Experience)
10/2023 - 01/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 01/2021
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 10/2012
3Neuroinflammatory Diseases
12/2021 - 09/2016
3Pathologic Constriction (Stenosis)
04/2021 - 12/2011
3Pancreatitis
10/2019 - 07/2019
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 10/2010
3Shock
10/2018 - 01/2006

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2005
18Biomarkers (Surrogate Marker)IBA
01/2024 - 10/2005
11Long Noncoding RNAIBA
03/2021 - 05/2012
9Therapeutic UsesIBA
04/2024 - 08/2004
9EnzymesIBA
09/2023 - 10/2006
9Messenger RNA (mRNA)IBA
03/2021 - 01/2003
8MicroRNAs (MicroRNA)IBA
05/2024 - 01/2013
7DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2007
7IntegrinsIBA
01/2020 - 01/2007
6AnticoagulantsIBA
06/2023 - 03/2006
6CytokinesIBA
10/2022 - 08/2004
6Glucose (Dextrose)FDA LinkGeneric
06/2022 - 10/2013
6HMGB1 Protein (HMG1)IBA
01/2021 - 12/2009
5Cisplatin (Platino)FDA LinkGeneric
06/2023 - 01/2007
5CalciumIBA
06/2022 - 06/2009
5Small Interfering RNA (siRNA)IBA
01/2021 - 08/2011
5CateninsIBA
02/2020 - 07/2013
5Liposomes (Liposome)IBA
02/2020 - 10/2010
5LigandsIBA
01/2020 - 10/2010
5Gefitinib (Iressa)FDA Link
02/2018 - 12/2007
4InterferonsIBA
03/2024 - 11/2010
4LipidsIBA
10/2023 - 01/2019
4GoldIBA
08/2023 - 02/2013
4Peptides (Polypeptides)IBA
09/2022 - 10/2010
4InflammasomesIBA
01/2018 - 10/2016
4ErbB Receptors (EGF Receptor)IBA
11/2012 - 12/2007
3AntigensIBA
03/2024 - 12/2009
3Neuroprotective AgentsIBA
01/2024 - 10/2016
3GlycosidesIBA
09/2023 - 01/2021
3Enoxaparin (Lovenox)FDA LinkGeneric
06/2023 - 01/2020
3Interleukin-13IBA
01/2023 - 01/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 10/2006
3Insulin (Novolin)FDA Link
01/2023 - 07/2018
3omega-Chloroacetophenone (Mace)IBA
01/2022 - 09/2018
3GlycogenIBA
10/2021 - 09/2015
3Paclitaxel (Taxol)FDA LinkGeneric
10/2021 - 10/2010
3fibrin fragment D (D-dimer)IBA
10/2020 - 03/2013
3Apolipoproteins E (ApoE)IBA
01/2019 - 10/2016
3Contrast MediaIBA
11/2018 - 11/2011
3Interleukin-6 (Interleukin 6)IBA
01/2018 - 08/2004
3AntithrombinsIBA
01/2018 - 02/2015
3Troponin IIBA
05/2016 - 03/2006
3Nitrogen DioxideIBA
01/2016 - 11/2010

Therapy/Procedure

37Therapeutics
10/2023 - 12/2005
8Percutaneous Coronary Intervention
01/2022 - 09/2011
6Drug Therapy (Chemotherapy)
08/2023 - 06/2008
6Stents
01/2020 - 09/2011
4Length of Stay
09/2022 - 05/2007
3Hematopoietic Stem Cell Transplantation
01/2022 - 12/2020
3Ligation
12/2017 - 01/2013